ArticlePloS one2022

Remdesivir plus Dexamethasone in COVID-19: A cohort study of severe patients requiring high flow oxygen therapy or non-invasive ventilation.

Gennaro De Pascale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.